Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16212 | TPP | 1/2 | 2 years, 9 months ago 10 March 2023 08:37:52 UTC | View, Job request 16212 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16211 | TPP | 2/2 | 2 years, 9 months ago 10 March 2023 08:23:07 UTC | View, Job request 16211 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16210 | TPP | 1/2 | 2 years, 9 months ago 10 March 2023 07:52:11 UTC | View, Job request 16210 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16209 | TPP | 2/2 | 2 years, 9 months ago 10 March 2023 07:27:18 UTC | View, Job request 16209 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15981 | TPP | 1/1 | 2 years, 9 months ago 03 March 2023 08:56:24 UTC | View, Job request 15981 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15980 | TPP | 1/1 | 2 years, 9 months ago 03 March 2023 08:50:28 UTC | View, Job request 15980 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15979 | TPP | 1/1 | 2 years, 9 months ago 03 March 2023 08:32:22 UTC | View, Job request 15979 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15977 | TPP | 1/2 | 2 years, 9 months ago 03 March 2023 00:21:22 UTC | View, Job request 15977 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15976 | TPP | 1/1 | 2 years, 9 months ago 02 March 2023 23:52:50 UTC | View, Job request 15976 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15974 | TPP | 1/1 | 2 years, 9 months ago 02 March 2023 23:38:31 UTC | View, Job request 15974 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15972 | TPP | 1/2 | 2 years, 9 months ago 02 March 2023 23:31:37 UTC | View, Job request 15972 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15968 | TPP | 1/1 | 2 years, 9 months ago 02 March 2023 22:40:24 UTC | View, Job request 15968 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15966 | TPP | 0/1 | 2 years, 9 months ago 02 March 2023 22:37:05 UTC | View, Job request 15966 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15528 | TPP | 1/1 | 2 years, 9 months ago 18 February 2023 21:44:30 UTC | View, Job request 15528 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14912 | TPP | 1/1 | 2 years, 10 months ago 03 February 2023 09:02:16 UTC | View, Job request 14912 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14542 | TPP | 1/1 | 2 years, 10 months ago 20 January 2023 03:46:25 UTC | View, Job request 14542 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14541 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 03:32:52 UTC | View, Job request 14541 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14540 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 03:24:08 UTC | View, Job request 14540 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14539 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 03:17:06 UTC | View, Job request 14539 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14538 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 03:07:58 UTC | View, Job request 14538 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14537 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 02:54:53 UTC | View, Job request 14537 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14536 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 01:15:59 UTC | View, Job request 14536 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14534 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 00:54:11 UTC | View, Job request 14534 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14533 | TPP | 0/1 | 2 years, 10 months ago 20 January 2023 00:50:42 UTC | View, Job request 14533 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14532 | TPP | 1/1 | 2 years, 10 months ago 20 January 2023 00:11:06 UTC | View, Job request 14532 |